Logistics and trucking companies also have filed for bankruptcy to reorganize their businesses and restructure debt, ...

Rein Therapeutics has dosed the first subject in a Phase II trial of LTI-03, its lead asset for treating idiopathic pulmonary ...

Trial is evaluating the safety, tolerability, and efficacy of LTI-03 in idiopathic pulmonary fibrosis (IPF) with topline interim data expected in the first half of 2026 AUSTIN, Texas, May 27 ...

Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines ...

Rein Therapeutics begins patient dosing in in RENEW phase 2 trial of LTI-03 to treat idiopathic pulmonary fibrosis: Austin, Texas Wednesday, May 28, 2025, 12:00 Hrs [IST] Rein The ...

Linden Technical Institute (LTI) bested defending champion Christianburg/Wismar by a 2-1 score-line when the ExxonMobil Linden Schools Football Championship resumed yesterday at the Wisburg ...

Trial is evaluating the safety, tolerability, and efficacy of LTI-03 in idiopathic pulmonary fibrosis (IPF) with topline interim data expected in the first half of ...